Home

Research

Conditions:

Funding types:

Region:

Priority:

Eye category:

Status

All

Active

Completed

Starting soon

Can nicotinamide protect and restore retinal ganglion cells in a model of autosomal dominant optic neuropathy?

Active

March 2024 - January 2025
Developing a model to study uveitis

Active

February 2024 - January 2025
Identifying potential targets for the monitoring and treatment of thyroid eye disease (TED)

Completed

January 2024 - July 2024
Analysis of Electroretinography using Artificial Intelligence with embedded safety features.

Starting soon

November 2024 - May 2027
Galectin-3 as a determinant of T cell-driven pathology: targeting galectin-3 to restore tissue integrity in uveitis and arthritis-associated uveitis.

Active

October 2024 - October 2027
Developing mitochondrial-targeted therapies for the multisystem management of diabetic eye disease

Active

September 2024 - September 2027
Tear proteomics and electrophysiology in infants at risk of retinopathy of prematurity

Active

September 2024 - August 2027
Corneal Nanoinjection: a nanoneedle platform for gene editing in inherited corneal endothelial disorders

Active

June 2024 - November 2024
Characterisation of the smooth zone of retinal autofluorescence in the macula of choroideremia patients as a biomarker for use as an approvable endpoint in a pivotal gene therapy trial

Active

June 2024 - May 2027